Domov › Rakovina prostaty › Arizona › Phoenix
Klinické štúdie Rakovina prostaty v meste Phoenix, AZ
17 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Phoenix a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Cancer Center at Saint Joseph's, Phoenix
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- Mayo Clinic Hospital in Arizona, Phoenix
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prebieha náborFáza 3
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Phoenix
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prebieha náborFáza 3
- Research Site, Phoenix
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Prebieha náborFáza 1/2
- GSK Investigational Site, Phoenix
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prebieha náborFáza 3
- Mayo Clinic in Arizona - Phoenix ( Site 0044), Phoenix
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Prebieha náborFáza 3
- Mayo Clinic- Phoenix, Phoenix
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Prebieha náborFáza 3
- Research Site, Phoenix
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Prebieha náborFáza 3
- Cancer Center at Saint Joseph's, Phoenix
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Mayo Clinic, Phoenix
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Prebieha náborFáza 1
- Mayo Clinic, Phoenix
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Prebieha náborFáza 2
- Mayo Clinic in Arizona, Phoenix
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prebieha náborFáza 3
- Cancer Center at Saint Joseph's, Phoenix
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Prebieha náborFáza 1/2
- Mayo Clinic, Phoenix
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Prebieha náborFáza 2
- Cancer Center at Saint Joseph's, Phoenix
Understanding of Genetics by Men at Risk for Prostate Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Mayo Clinic, Phoenix
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Prebieha náborFáza 3
- Cancer Center at Saint Joseph's, Phoenix
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Los Angeles, CA61 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Baltimore, MD43 štúdií
- Nashville, TN42 štúdií
- Seattle, WA42 štúdií
- Washington, DC38 štúdií
Iné štúdie v Phoenix
- Rakovina prsníka25 štúdií
- Kolorektálny karcinóm25 štúdií
- Obézita22 štúdií
- Nemalobunkový karcinóm pľúc20 štúdií
- Metastatická rakovina20 štúdií
- Srdcové zlyhanie18 štúdií
- Rakovina (všetky typy)17 štúdií
- Mnohonásobný myelóm16 štúdií
- Rakovina pankreasu16 štúdií
- Kardiovaskulárne ochorenia16 štúdií
- Alzheimerova choroba15 štúdií
- Nadváha15 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.